CIK 0001752828
- Emerging growth company
Celularity Inc
Sign in to watch- Ticker
- CELU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831702591
- Phone
- +1 908-768-2170
- Business address
- 170 PARK AVE, FLORHAM PARK, NJ, 07932
- Former names
- GX Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-16 | Jones Anne Chief Business Officer | Shares withheld for taxes | −3,734 | $1.89 | $7K | 49,154 |
| 2022-07-13 | Jones Anne Chief Business Officer | Grant or award | +11,483 | 27,888 | ||
| 2022-07-13 | Jones Anne Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +33,670 | 33,670 | ||
| 2022-04-13 | Jones Anne Chief Business Officer | Grant or award | +16,405 | 16,405 | ||
| 2022-04-13 | Jones Anne Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +48,100 | 48,100 | ||
| 2021-11-16 | Jones Anne Chief Business Officer | Grant or award | +25,000 | 52,888 | ||
| 2021-07-16 | Jones Anne Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +96,074 | 96,074 |
Page 1 of 1 · 7 trades